Sinopharm Group (01099) elects Jin Bin as chairman

Zhitong Finance APP News, Sinopharm Group (01099) announced that the Board of Directors resolved to elect Mr. Jin Bin as Chairman of the Board of Directors and Mr. Chen Qiyu as Vice Chairman of the Board of Directors. The Board of Directors resolved to approve that the seventh session of the Strategy and Investment Committee of the Board of Directors shall consist of nine directors, including Mr. Jin Bin, Mr. Chen Qiyu, Mr. Li Peiyu, Mr. Shi Shenghao, Mr. Chen Weiru, Mr. Lian Wanyong, Mr. Yang Binghua, Mr. Chen Yuqing, and Mr. Wen Deyong. Mr. Jin Bin shall serve as the Chairman of the Strategy and Investment Committee. The Board of Directors resolved to approve that the seventh session of the Nomination Committee of the Board of Directors shall consist of six directors, namely Mr. Jin Bin, Mr. Wu Delong, Mr. Yu Weifeng, Mr. Shi Shenghao, Mr. Chen Weiru, and Ms. Li Ying. Mr. Jin Bin shall serve as the Chairman of the Nomination Committee. The Board of Directors resolved to approve that the seventh session of the Audit Committee of the Board of Directors shall consist of five directors, namely Mr. Wu Delong, Mr. Li Peiyu, Mr. Shi Shenghao, Mr. Zu Jing, and Mr. Wen Deyong. Mr. Wu Delong shall serve as the Chairman of the Audit Committee. The Board of Directors resolved to approve that the seventh session of the Remuneration Committee of the Board of Directors shall consist of three directors, namely Mr. Li Peiyu, Mr. Wu Delong, and Mr. Yu Weifeng. Mr. Li Peiyu shall serve as the Chairman of the Remuneration Committee. The Board of Directors resolved to approve that the seventh session of the Legal Compliance and Environmental, Social and Governance Committee of the Board of Directors shall consist of four directors, namely Mr. Yu Weifeng, Mr. Jin Bin, Mr. Lian Wanyong, and Mr. Xing Yonggang. Mr. Yu Weifeng shall serve as the Chairman of the Legal Compliance and Environmental, Social and Governance Committee.